tiprankstipranks
Trending News
More News >
Shanghai Pharmaceuticals Holding Co Class H (SHPMF)
:SHPMF
US Market
Advertisement

Shanghai Pharmaceuticals Holding Co (SHPMF) Ratios

Compare
10 Followers

Shanghai Pharmaceuticals Holding Co Ratios

SHPMF's free cash flow for Q1 2025 was ¥0.10. For the 2025 fiscal year, SHPMF's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.36 1.33 1.35 1.27 1.22
Quick Ratio
1.07 1.03 1.04 0.97 0.95
Cash Ratio
0.28 0.25 0.25 0.24 0.25
Solvency Ratio
0.04 0.05 0.07 0.07 0.07
Operating Cash Flow Ratio
0.08 0.04 0.04 0.06 0.08
Short-Term Operating Cash Flow Coverage
0.24 0.15 0.17 0.22 0.34
Net Current Asset Value
¥ 36.74B¥ 30.79B¥ 29.38B¥ 12.13B¥ 13.12B
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.20 0.19 0.19 0.21
Debt-to-Equity Ratio
0.70 0.63 0.58 0.64 0.70
Debt-to-Capital Ratio
0.41 0.38 0.37 0.39 0.41
Long-Term Debt-to-Capital Ratio
0.08 0.08 0.09 0.13 0.03
Financial Leverage Ratio
3.09 3.09 2.95 3.31 3.29
Debt Service Coverage Ratio
0.19 0.24 0.36 0.36 0.41
Interest Coverage Ratio
4.98 4.61 5.34 5.40 5.09
Debt to Market Cap
0.78 1.06 0.85 0.87 0.65
Interest Debt Per Share
14.20 12.04 11.56 11.68 11.68
Net Debt to EBITDA
1.40 1.14 0.90 0.88 0.91
Profitability Margins
Gross Profit Margin
10.62%11.88%13.14%13.23%14.30%
EBIT Margin
3.32%3.35%4.41%3.90%4.33%
EBITDA Margin
3.83%4.19%5.36%4.89%5.44%
Operating Profit Margin
2.89%2.95%3.89%3.80%3.74%
Pretax Profit Margin
2.75%2.71%3.80%3.77%3.74%
Net Profit Margin
1.58%1.45%2.42%2.36%2.34%
Continuous Operations Profit Margin
2.05%1.98%3.01%2.91%2.92%
Net Income Per EBT
57.20%53.41%63.77%62.54%62.66%
EBT Per EBIT
95.38%92.01%97.71%99.25%99.88%
Return on Assets (ROA)
1.92%1.78%2.84%3.12%3.01%
Return on Equity (ROE)
6.08%5.50%8.38%10.32%9.91%
Return on Capital Employed (ROCE)
8.38%8.56%10.31%11.46%11.77%
Return on Invested Capital (ROIC)
4.17%4.49%6.21%6.72%6.91%
Return on Tangible Assets
2.08%1.94%3.12%3.49%3.40%
Earnings Yield
6.17%9.70%14.07%14.89%13.77%
Efficiency Ratios
Receivables Turnover
3.02 3.37 3.31 3.54 3.46
Payables Turnover
4.08 4.20 3.91 4.46 7.18
Inventory Turnover
6.52 6.26 5.85 6.91 6.83
Fixed Asset Turnover
14.50 14.22 14.33 14.02 13.50
Asset Turnover
1.22 1.23 1.17 1.32 1.29
Working Capital Turnover Ratio
5.97 6.60 7.31 9.79 8.94
Cash Conversion Cycle
87.42 79.54 79.45 74.15 108.24
Days of Sales Outstanding
120.84 108.20 110.43 103.17 105.60
Days of Inventory Outstanding
56.02 58.28 62.42 52.82 53.46
Days of Payables Outstanding
89.43 86.94 93.41 81.85 50.81
Operating Cycle
176.85 166.48 172.86 156.00 159.06
Cash Flow Ratios
Operating Cash Flow Per Share
2.80 1.41 1.36 1.78 2.41
Free Cash Flow Per Share
2.00 0.61 0.59 0.33 1.35
CapEx Per Share
0.61 0.80 0.77 1.45 1.06
Free Cash Flow to Operating Cash Flow
0.72 0.43 0.43 0.19 0.56
Dividend Paid and CapEx Coverage Ratio
1.81 0.75 0.82 0.74 1.26
Capital Expenditure Coverage Ratio
4.59 1.76 1.77 1.23 2.27
Operating Cash Flow Coverage Ratio
0.20 0.12 0.12 0.16 0.22
Operating Cash Flow to Sales Ratio
0.04 0.02 0.02 0.02 0.04
Free Cash Flow Yield
11.67%5.82%5.16%2.76%11.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.20 10.31 7.11 6.72 7.26
Price-to-Sales (P/S) Ratio
0.23 0.15 0.17 0.16 0.17
Price-to-Book (P/B) Ratio
0.96 0.57 0.60 0.69 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
8.57 17.18 19.39 36.29 8.52
Price-to-Operating Cash Flow Ratio
6.79 7.42 8.42 6.76 4.77
Price-to-Earnings Growth (PEG) Ratio
-3.32 -0.28 -0.71 0.51 0.75
Price-to-Fair Value
0.96 0.57 0.60 0.69 0.72
Enterprise Value Multiple
7.42 4.70 4.11 4.12 4.04
Enterprise Value
78.40B 51.22B 51.08B 43.51B 42.16B
EV to EBITDA
7.42 4.70 4.11 4.12 4.04
EV to Sales
0.28 0.20 0.22 0.20 0.22
EV to Free Cash Flow
10.57 22.65 24.81 46.16 10.99
EV to Operating Cash Flow
7.57 9.79 10.77 8.60 6.16
Tangible Book Value Per Share
18.48 16.91 17.25 14.61 13.36
Shareholders’ Equity Per Share
19.72 18.51 19.26 17.37 15.96
Tax and Other Ratios
Effective Tax Rate
0.28 0.27 0.21 0.23 0.22
Revenue Per Share
74.45 70.33 66.61 75.94 67.52
Net Income Per Share
1.17 1.02 1.61 1.79 1.58
Tax Burden
0.57 0.53 0.64 0.63 0.63
Interest Burden
0.83 0.81 0.86 0.97 0.86
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
4.12 1.01 0.68 0.81 1.22
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis